←Back to structures
S16_GE16_scaffold_10741_prodigal-single.1__X__X__00298
Bact-VirS16_GE16_scaffold_10741_prodigal-single.1__X__X__00298
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 6-96
Domain cluster:
representative
CATH (69)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.80 | 63.0 | 5.19e-01 | 82.4% | 89.5% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 62.0 | 5.50e-01 | 82.4% | 98.4% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.79 | 61.0 | 5.32e-01 | 81.3% | 97.7% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 60.0 | 5.43e-01 | 82.4% | 98.3% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.77 | 60.0 | 5.02e-01 | 82.4% | 91.9% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 59.0 | 5.18e-01 | 81.3% | 90.8% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 60.0 | 5.30e-01 | 82.4% | 95.3% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 59.0 | 5.11e-01 | 82.4% | 91.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 60.0 | 4.85e-01 | 83.5% | 90.4% |
| 2f86B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 58.0 | 5.10e-01 | 80.2% | 95.3% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 57.0 | 4.76e-01 | 79.1% | 98.7% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 59.0 | 5.16e-01 | 82.4% | 91.7% |
| 7c5wA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 57.0 | 4.80e-01 | 79.1% | 98.0% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 57.0 | 5.20e-01 | 80.2% | 100.0% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 63.0 | 5.31e-01 | 90.1% | 95.3% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 58.0 | 5.08e-01 | 81.3% | 93.9% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 61.0 | 5.28e-01 | 89.0% | 94.4% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 58.0 | 5.11e-01 | 82.4% | 90.7% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 59.0 | 5.16e-01 | 84.6% | 89.5% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 58.0 | 5.03e-01 | 82.4% | 87.3% |
| 5dvyA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.74 | 56.0 | 4.95e-01 | 79.1% | 88.1% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.73 | 57.0 | 4.91e-01 | 82.4% | 92.8% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 55.0 | 4.94e-01 | 80.2% | 93.6% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 57.0 | 5.00e-01 | 83.5% | 89.5% |
| 3g8zA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 56.0 | 4.95e-01 | 81.3% | 89.1% |
| 1nu3A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 55.0 | 4.69e-01 | 81.3% | 76.6% |
| 3lh4A00 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 55.0 | 5.07e-01 | 81.3% | 84.3% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 54.0 | 4.82e-01 | 81.3% | 86.9% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 57.0 | 5.11e-01 | 85.7% | 95.2% |
| 4j8tA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 55.0 | 4.91e-01 | 82.4% | 93.8% |
| 2bngC00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 55.0 | 4.81e-01 | 84.6% | 79.3% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 54.0 | 4.71e-01 | 81.3% | 90.4% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 52.0 | 4.77e-01 | 78.0% | 94.1% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.69 | 58.0 | 4.99e-01 | 91.2% | 91.0% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 53.0 | 4.76e-01 | 82.4% | 89.9% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.69 | 52.0 | 4.90e-01 | 79.1% | 100.0% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 55.0 | 4.88e-01 | 85.7% | 90.8% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 53.0 | 4.70e-01 | 82.4% | 89.4% |
| 1wnhA02 | 3.10.450.10 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 53.0 | 4.83e-01 | 82.4% | 69.2% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 52.0 | 4.56e-01 | 81.3% | 84.4% |
| 1ewfA02 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.68 | 51.0 | 3.70e-01 | 82.4% | 45.3% |
| 4ec6A00 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 54.0 | 5.11e-01 | 86.8% | 96.3% |
| 2obdA01 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.67 | 51.0 | 3.61e-01 | 81.3% | 43.1% |
| 7knlA01 | 2.40.128.30 | Mainly Beta › Beta Barrel › Lipocalin › Avidin-like | 0.64 | 50.0 | 4.68e-01 | 84.6% | 91.2% |
| 4bg7A00 | 2.30.31.10 | Mainly Beta › Roll › Transcriptional Co-activator pc4; Chain A › Transcriptional Coactivator Pc4; Chain A | 0.63 | 50.0 | 4.90e-01 | 94.5% | 78.6% |
| 1ut7B01 | 2.170.150.80 | Mainly Beta › Beta Complex › Metal Binding Protein, Guanine Nucleotide Exchange Factor; Chain A › NAC domain | 0.61 | 44.0 | 4.01e-01 | 78.0% | 56.0% |
| 3eliA00 | 3.30.530.20 | Alpha Beta › 2-Layer Sandwich › Alpha-D-Glucose-1,6-Bisphosphate; Chain A, domain 4 › START domain | 0.60 | 45.0 | 3.89e-01 | 89.0% | 50.0% |
| 7x7zA01 | 2.40.480.10 | Mainly Beta › Beta Barrel › AOC barrel-like › Allene oxide cyclase-like | 0.60 | 45.0 | 4.00e-01 | 81.3% | 74.1% |
| 3imhA00 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.60 | 47.0 | 3.21e-01 | 84.6% | 86.1% |
| 2lyxA00 | 3.10.450.390 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › Protein of unknown function DUF3889 | 0.60 | 45.0 | 4.61e-01 | 81.3% | 86.2% |
| 2z0uA00 | 2.60.40.150 | Mainly Beta › Sandwich › Immunoglobulin-like › C2 domain | 0.60 | 41.0 | 3.61e-01 | 70.3% | 81.2% |
| 3ci0K01 | 3.30.1300.30 | Alpha Beta › 2-Layer Sandwich › Pantoate--beta-alanine Ligase; Chain: A,domain 2 › GSPII I/J protein-like | 0.57 | 46.0 | 4.45e-01 | 86.8% | 75.0% |
| 3kstA00 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.57 | 47.0 | 3.34e-01 | 91.2% | 56.7% |
| 5c0pA00 | 2.115.10.20 | Mainly Beta › 5 Propeller › Tachylectin-2; Chain A › Glycosyl hydrolase domain; family 43 | 0.57 | 48.0 | 3.43e-01 | 93.4% | 51.1% |
| 3fzxA00 | 2.40.360.20 | Mainly Beta › Beta Barrel › YmcC-like fold › | 0.56 | 44.0 | 3.40e-01 | 84.6% | 42.5% |
| 6secA03 | 2.70.98.10 | Mainly Beta › Distorted Sandwich › Beta-galactosidase; Chain A, domain 5 › | 0.56 | 42.0 | 3.07e-01 | 82.4% | 40.1% |
| 4eg9A00 | 2.50.20.40 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.55 | 44.0 | 3.38e-01 | 89.0% | 91.3% |
| 2ichA01 | 2.40.370.10 | Mainly Beta › Beta Barrel › AttH-like fold › AttH-like domain | 0.55 | 41.0 | 3.36e-01 | 80.2% | 52.5% |
| 2oq8A00 | 2.60.40.2930 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.55 | 48.0 | 4.05e-01 | 94.5% | 92.7% |
| 1ul7A00 | 3.30.310.80 | Alpha Beta › 2-Layer Sandwich › TATA-Binding Protein › Kinase associated domain 1, KA1 | 0.54 | 35.0 | 3.46e-01 | 81.3% | 59.8% |
| 3wlvA00 | 3.10.270.10 | Alpha Beta › Roll › Urate Oxidase › Urate Oxidase; | 0.54 | 44.0 | 3.20e-01 | 95.6% | 97.4% |
| 2qxlB05 | 2.60.34.10 | Mainly Beta › Sandwich › Substrate Binding Domain Of DNAk; Chain A, domain 1 › Substrate Binding Domain Of DNAk; Chain A, domain 1 | 0.53 | 45.0 | 4.03e-01 | 92.3% | 81.1% |
| 4ghbA00 | 2.40.160.190 | Mainly Beta › Beta Barrel › Porin › | 0.52 | 42.0 | 3.02e-01 | 85.7% | 50.6% |
| 7a0hA02 | 3.90.1150.210 | Alpha Beta › Alpha-Beta Complex › Aspartate Aminotransferase, domain 1 › F-actin capping protein, beta subunit | 0.52 | 41.0 | 3.36e-01 | 85.7% | 65.5% |
| 3k5iA03 | 3.30.470.20 | Alpha Beta › 2-Layer Sandwich › D-amino Acid Aminotransferase; Chain A, domain 1 › ATP-grasp fold, B domain | 0.51 | 43.0 | 3.50e-01 | 98.9% | 97.5% |
| 2h41A00 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.51 | 33.0 | 3.28e-01 | 85.7% | 62.1% |
| 3fdwA00 | 2.60.40.150 | Mainly Beta › Sandwich › Immunoglobulin-like › C2 domain | 0.51 | 41.0 | 3.67e-01 | 90.1% | 61.5% |
| 4n68A00 | 2.60.40.10 | Mainly Beta › Sandwich › Immunoglobulin-like › Immunoglobulins | 0.50 | 32.0 | 3.19e-01 | 71.4% | 58.6% |
| 6kxkB02 | 2.60.40.150 | Mainly Beta › Sandwich › Immunoglobulin-like › C2 domain | 0.50 | 42.0 | 3.75e-01 | 94.5% | 77.8% |
ECOD (95)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 5040972 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.83 | 66.0 | 7.19e-01 | 87.9% | 100.0% |
| 5034706 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.83 | 65.0 | 7.15e-01 | 83.5% | 100.0% |
| 3725005 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.80 | 63.0 | 5.43e-01 | 82.4% | 90.4% |
| 5056218 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.80 | 59.0 | 6.61e-01 | 80.2% | 100.0% |
| 3971296 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.80 | 60.0 | 5.30e-01 | 79.1% | 88.4% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.79 | 63.0 | 5.03e-01 | 83.5% | 86.4% |
| 3286088 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.79 | 61.0 | 5.57e-01 | 82.4% | 99.2% |
| 4472109 | 243.1.1.103 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF30257 | 0.79 | 61.0 | 5.52e-01 | 81.3% | 89.2% |
| 3961892 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.77 | 62.0 | 5.29e-01 | 84.6% | 88.6% |
| None | — | 0.77 | 59.0 | 5.34e-01 | 80.2% | 95.8% | |
| 3734807 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 60.0 | 4.83e-01 | 82.4% | 68.2% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.77 | 60.0 | 5.43e-01 | 82.4% | 98.3% |
| 4254866 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.77 | 57.0 | 5.11e-01 | 78.0% | 89.6% |
| 3674547 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.77 | 60.0 | 5.05e-01 | 83.5% | 81.3% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.76 | 60.0 | 5.17e-01 | 83.5% | 89.9% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.75 | 61.0 | 4.99e-01 | 85.7% | 85.0% |
| 2841938 | 243.1.1.81 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF27546 | 0.75 | 60.0 | 4.73e-01 | 84.6% | 86.2% |
| 6408 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.75 | 63.0 | 5.30e-01 | 90.1% | 94.6% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.75 | 61.0 | 5.17e-01 | 86.8% | 88.3% |
| 3289451 | 243.1.1.63 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF6841 | 0.75 | 59.0 | 5.04e-01 | 83.5% | 92.1% |
| 3967804 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 57.0 | 5.47e-01 | 81.3% | 91.4% |
| 3596331 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.74 | 58.0 | 5.13e-01 | 82.4% | 92.2% |
| 3284315 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 59.0 | 5.24e-01 | 83.5% | 99.2% |
| 3307679 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.74 | 57.0 | 4.95e-01 | 82.4% | 83.6% |
| 3280539 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 60.0 | 5.32e-01 | 86.8% | 98.5% |
| 4020443 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 57.0 | 5.18e-01 | 83.5% | 95.1% |
| 4074364 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 57.0 | 5.01e-01 | 82.4% | 82.3% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 59.0 | 4.90e-01 | 86.8% | 83.2% |
| 3453643 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 57.0 | 4.82e-01 | 82.4% | 82.1% |
| 3724634 | 243.1.1.63 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF6841 | 0.73 | 61.0 | 5.25e-01 | 90.1% | 92.1% |
| 4193401 | 243.1.1.34 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › YchJ_M-like | 0.73 | 56.0 | 5.25e-01 | 81.3% | 96.4% |
| 4608992 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.72 | 57.0 | 4.71e-01 | 83.5% | 91.1% |
| 3710733 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 56.0 | 5.10e-01 | 82.4% | 95.8% |
| 3807566 | 331.3.1.28 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › DUF220 | 0.72 | 50.0 | 4.13e-01 | 74.7% | 41.9% |
| 6390 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.72 | 55.0 | 5.02e-01 | 80.2% | 96.6% |
| 4373837 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.72 | 57.0 | 4.92e-01 | 84.6% | 94.3% |
| 3930653 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.72 | 55.0 | 5.62e-01 | 81.3% | 91.1% |
| 3818687 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.72 | 55.0 | 4.70e-01 | 81.3% | 77.2% |
| 3808998 | 331.3.1.28 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › DUF220 | 0.72 | 58.0 | 4.30e-01 | 84.6% | 38.0% |
| 3214004 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 57.0 | 5.51e-01 | 84.6% | 98.0% |
| 3407993 | 243.1.1.40 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NXF_NTF2 | 0.71 | 60.0 | 4.73e-01 | 90.1% | 86.7% |
| 3511571 | 883.1.1.2 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP_C | 0.71 | 55.0 | 3.96e-01 | 83.5% | 49.4% |
| 3262201 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 54.0 | 4.63e-01 | 81.3% | 80.0% |
| 3807674 | 331.3.1.28 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › DUF220 | 0.71 | 57.0 | 4.10e-01 | 84.6% | 35.3% |
| 3297404 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.70 | 54.0 | 4.66e-01 | 81.3% | 98.6% |
| 3940802 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.70 | 55.0 | 5.22e-01 | 82.4% | 85.7% |
| 3961157 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.70 | 50.0 | 4.53e-01 | 73.6% | 56.7% |
| 3315222 | 243.1.1.89 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF7074 | 0.70 | 53.0 | 5.19e-01 | 80.2% | 80.0% |
| 4131272 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 53.0 | 4.44e-01 | 81.3% | 81.3% |
| 4561192 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.69 | 52.0 | 5.50e-01 | 79.1% | 96.2% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.69 | 57.0 | 5.22e-01 | 90.1% | 97.5% |
| 3808162 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 57.0 | 5.76e-01 | 92.3% | 91.1% |
| 4865157 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.68 | 59.0 | 5.41e-01 | 93.4% | 91.4% |
| 3721524 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 54.0 | 4.71e-01 | 86.8% | 92.1% |
| 3432676 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.67 | 61.0 | 5.12e-01 | 97.8% | 64.9% |
| 1807441 | 243.1.1.37 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcpC-like_C | 0.67 | 54.0 | 5.11e-01 | 86.8% | 96.3% |
| None | — | 0.67 | 53.0 | 3.08e-01 | 82.4% | 13.8% | |
| 2886759 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.66 | 52.0 | 4.49e-01 | 83.5% | 84.2% |
| 3606232 | 331.4.1.0 ↗ | a+b two layers › TBP-like › Kinase associated domain 1, KA1 › Kinase associated domain 1, KA1 | 0.66 | 48.0 | 4.67e-01 | 81.3% | 68.0% |
| 3433417 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.66 | 59.0 | 5.66e-01 | 97.8% | 91.4% |
| 3466996 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.66 | 50.0 | 4.53e-01 | 79.1% | 90.0% |
| 3395729 | 331.3.1.0 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like | 0.64 | 51.0 | 4.24e-01 | 85.7% | 53.1% |
| 3935161 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.64 | 52.0 | 4.95e-01 | 86.8% | 81.0% |
| 3628642 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.64 | 56.0 | 3.81e-01 | 100.0% | 51.5% |
| 3805022 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.64 | 51.0 | 4.61e-01 | 85.7% | 72.0% |
| 3376439 | 5.1.4.276 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › WD40, Beta-prop_WDR75_2nd | 0.64 | 59.0 | 3.82e-01 | 100.0% | 45.2% |
| 3958869 | 881.1.1.0 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like | 0.64 | 54.0 | 4.05e-01 | 94.5% | 37.7% |
| 3575714 | 5.1.4.329 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › PF30693 | 0.64 | 56.0 | 3.71e-01 | 100.0% | 47.2% |
| 3591282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.63 | 48.0 | 4.44e-01 | 82.4% | 97.5% |
| 3962319 | 881.1.1.0 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like | 0.62 | 51.0 | 4.31e-01 | 89.0% | 58.7% |
| 3496336 | 5.1.4.0 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed | 0.62 | 51.0 | 3.27e-01 | 90.1% | 35.3% |
| 3824851 | 5084.5.1.43 ↗ | beta barrels › Outer membrane meander beta-barrels › Porins › Porin › PF30985 | 0.62 | 49.0 | 4.06e-01 | 85.7% | 48.5% |
| 4436313 | 295.1.1.0 ↗ | a+b two layers › ssDNA-binding transcriptional regulator domain-like › ssDNA-binding transcriptional regulator domain › ssDNA-binding transcriptional regulator domain | 0.62 | 48.0 | 4.84e-01 | 92.3% | 83.3% |
| 3622132 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.61 | 52.0 | 4.52e-01 | 94.5% | 91.4% |
| 3675696 | 5.1.4.288 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › APEH_N | 0.61 | 52.0 | 3.31e-01 | 95.6% | 46.7% |
| 3666444 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.60 | 47.0 | 3.74e-01 | 84.6% | 44.3% |
| 3697493 | 5.1.5.70 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed › TFIIIC_delta | 0.60 | 52.0 | 3.39e-01 | 94.5% | 50.4% |
| 5078784 | 2003.1.5.82 ↗ | a/b three-layered sandwiches › Rossmann-like › Rossmann-related › S-adenosyl-L-methionine-dependent methyltransferases › Methyltransf_31 | 0.59 | 41.0 | 3.01e-01 | 72.5% | 35.9% |
| 3748213 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.59 | 46.0 | 3.32e-01 | 84.6% | 31.4% |
| 3407004 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.59 | 46.0 | 3.49e-01 | 83.5% | 53.6% |
| 3412367 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.59 | 45.0 | 3.69e-01 | 83.5% | 65.2% |
| 3170490 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.59 | 46.0 | 3.47e-01 | 84.6% | 37.8% |
| 4029652 | 5.1.4.16 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 7-bladed › CPSF_A | 0.59 | 53.0 | 3.47e-01 | 100.0% | 49.2% |
| 3925906 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.58 | 48.0 | 4.24e-01 | 90.1% | 93.3% |
| 3739762 | 330.6.1.1 ↗ | a+b two layers › dsRBD-like › 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain › 2-isopropylmalate synthase LeuA, allosteric (dimerisation) domain › LeuA_dimer | 0.58 | 43.0 | 3.90e-01 | 78.0% | 60.0% |
| 3269932 | 5.1.5.27 ↗ | beta duplicates or obligate multimers › beta-propeller-like › beta-propeller › 8-bladed › APEH_N | 0.57 | 49.0 | 3.21e-01 | 100.0% | 51.7% |
| 1388524 | 243.17.1.1 ↗ | a+b two layers › Cystatin-like › C-terminal domain of PatG › C-terminal domain of PatG › PatG_C | 0.57 | 44.0 | 3.90e-01 | 82.4% | 65.4% |
| 3967227 | 9.3.1.0 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like | 0.56 | 45.0 | 3.66e-01 | 87.9% | 87.8% |
| 4158607 | 71.1.1.5 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › DUF576 | 0.55 | 41.0 | 3.03e-01 | 76.9% | 32.8% |
| 4225086 | 222.1.1.17 ↗ | a+b two layers › Thioesterase/thiol ester dehydrase-isomerase-like › Thioesterase/thiol ester dehydrase-isomerase › Thioesterase/thiol ester dehydrase-isomerase › PKS_DH_N | 0.54 | 42.0 | 3.53e-01 | 85.7% | 75.8% |
| 5055280 | 331.4.1.0 ↗ | a+b two layers › TBP-like › Kinase associated domain 1, KA1 › Kinase associated domain 1, KA1 | 0.53 | 40.0 | 3.45e-01 | 81.3% | 51.7% |
| 4648616 | 222.1.1.17 ↗ | a+b two layers › Thioesterase/thiol ester dehydrase-isomerase-like › Thioesterase/thiol ester dehydrase-isomerase › Thioesterase/thiol ester dehydrase-isomerase › PKS_DH_N | 0.53 | 40.0 | 3.36e-01 | 82.4% | 80.6% |
| 3986557 | 2484.1.1.199 ↗ | mixed a+b and a/b › Ribonuclease H-like › Ribonuclease H-like › Ribonuclease H-like › Transposase_mut | 0.51 | 35.0 | 3.32e-01 | 71.4% | 77.4% |
| 4288637 | 222.1.1.17 ↗ | a+b two layers › Thioesterase/thiol ester dehydrase-isomerase-like › Thioesterase/thiol ester dehydrase-isomerase › Thioesterase/thiol ester dehydrase-isomerase › PKS_DH_N | 0.50 | 38.0 | 3.27e-01 | 83.5% | 80.0% |
| 3404544 | 511.1.1.1 ↗ | beta sandwiches › Heat shock protein 70kD (HSP70), peptide-binding domain › Heat shock protein 70kD (HSP70), peptide-binding domain › Heat shock protein 70kD (HSP70), peptide-binding domain › HSP70 | 0.50 | 41.0 | 3.71e-01 | 89.0% | 84.0% |